Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Galderma R&D
This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application as measured by the Corneometer CM 825.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of moderate to severe rosacea, defined as the presence of at least moderate erythema with telangiectasia and a minimum of two inflammatory lesions
You may not be if
Individuals with active symptoms of allergy (mild active seasonal allergies are acceptable) or atopic dermatitis
Clareo Health | Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application
